semaglutide heart rate increase and variability (HRV) & Resting heart rate (RHR) : r/ Semaglutide Semaglutide 2.4 mg delivered a

A 2023 study found that 67% of IBD patients reported either no gastrointestinal worsening or actual symptom improvement on GLP-1 therapy, though individual responses vary significantly based on disease activity and genetic factors

At the American College of Cardiology meetings today, with simultaneous publication in NEJM, was a new randomized trial of semaglutide in 616 participants with heart failure with preserved ejection fraction, obesity and Type 2 diabetes

Professional skin treatments cost more than drugstore products, and its important to be realistic about your budget

Summary and clinical implications Current clinical and preclinical data suggest a complex relationship between GLP-1RAs and the risk of PDAC (Fig

Verdict: For a power outage under 4 hours, do not worry at all

Will I regain weight after stopping treatment